Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1011238
Abstract: Mutations in KCNH6 has been proved to cause hypoinsulinemia and diabetes in human and mice. Cisapride is a stomach–intestinal motility drug used to treat gastrointestinal dysfunction. Cisapride has been reported to be a potential inhibitor…
read more here.
Keywords:
cisapride induced;
induced hypoglycemia;
kcnh6 potassium;
potassium channel ... See more keywords